Verastem - 13 Year Stock Price History | VSTM

Historical daily share price chart and data for Verastem since 2012 adjusted for splits and dividends. The latest closing stock price for Verastem as of May 02, 2025 is 7.43.
  • The all-time high Verastem stock closing price was 210.84 on July 10, 2013.
  • The Verastem 52-week high stock price is 13.52, which is 82% above the current share price.
  • The Verastem 52-week low stock price is 2.10, which is 71.7% below the current share price.
  • The average Verastem stock price for the last 52 weeks is 4.72.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Verastem Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 6.0876 6.4900 7.5300 4.5200 7.4300 43.71%
2024 6.5466 8.3000 14.0700 2.2000 5.1700 -36.49%
2023 7.5211 5.0280 12.4800 4.2000 8.1400 68.53%
2022 12.9754 25.2000 25.2000 3.5424 4.8300 -80.37%
2021 34.5483 26.4000 58.2000 22.8000 24.6000 -3.76%
2020 22.0013 15.9600 50.4000 13.3200 25.5600 58.96%
2019 23.0023 43.3200 49.0800 10.3248 16.0800 -60.12%
2018 65.3020 38.5200 119.6400 34.5600 40.3200 9.45%
2017 33.4821 13.8000 64.9200 13.5600 36.8400 174.11%
2016 16.1705 21.3600 22.3200 12.8400 13.4400 -39.78%
2015 77.9317 113.4000 145.2000 19.3200 22.3200 -79.65%
2014 119.9300 149.7600 194.5200 85.6800 109.6800 -19.82%
2013 136.5188 118.8000 210.8400 105.4800 136.8000 29.69%
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.383B $0.000B
Verastem, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing drugs to improve outcomes for patients with cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. Its lead FAK inhibitor is defactinib (VS-6063), an orally available candidate for combination therapy with immuno-oncology agents and other anti-cancer compounds. The company's defactinib is in Phase 1b study for the treatment of pancreatic cancer, as well as in Phase 1/2 clinical trial for the treatment of ovarian cancer, non-small cell lung cancer, mesothelioma, and pancreatic cancer. It also engages in developing duvelisib, an investigational oral therapy that targets the PI3K signaling pathway, as well as attacks malignant B-cells and T-cells and disrupt the tumor microenvironment to help thwart their growth and proliferation for patients with lymphatic cancers through the dual inhibition of PI3K delta and gamma.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) GB $224.654B 16.77
Amgen (AMGN) US $151.198B 13.55
Gilead Sciences (GILD) US $129.098B 13.40
Vertex Pharmaceuticals (VRTX) US $128.836B 0.00
Bristol Myers Squibb (BMY) US $102.914B 6.89
GSK (GSK) GB $80.610B 9.58
CSL (CSLLY) AU $80.379B 0.00
Regeneron Pharmaceuticals (REGN) US $66.208B 15.87
Argenex SE (ARGX) NL $39.669B 272.97
Alnylam Pharmaceuticals (ALNY) US $33.821B 0.00
BeiGene (ONC) KY $25.298B 0.00
BioNTech SE (BNTX) DE $25.183B 0.00
Biogen (BIIB) US $18.101B 7.81
Genmab (GNMSF) DK $14.542B 14.98
Genmab (GMAB) DK $13.773B 17.32
Insmed (INSM) US $13.146B 0.00
Illumina (ILMN) US $12.326B 31.79
Incyte (INCY) US $12.104B 91.96
BioMarin Pharmaceutical (BMRN) US $11.836B 19.32
Exelixis (EXEL) US $10.913B 22.63
Swedish Orphan Biovitrum (BIOVF) SE $10.858B 27.73
Moderna (MRNA) US $10.678B 0.00
Ascendis Pharma (ASND) DK $10.491B 0.00
Exact Sciences (EXAS) US $9.724B 0.00
QIAGEN (QGEN) NL $9.587B 19.30
Roivant Sciences (ROIV) GB $8.192B 0.00
Bio-Techne Corp (TECH) US $7.982B 30.60
Repligen (RGEN) US $7.946B 89.00
Revolution Medicines (RVMD) US $7.585B 0.00
Halozyme Therapeutics (HALO) US $7.559B 15.61
Jazz Pharmaceuticals (JAZZ) IE $7.399B 6.59
TG Therapeutics (TGTX) US $6.897B 310.29
Blueprint Medicines (BPMC) US $6.758B 0.00
Bio-Rad Laboratories (BIO.B) US $6.566B 22.20
Telix Pharmaceuticals (TLX) AU $6.318B 0.00
Sarepta Therapeutics (SRPT) US $6.240B 29.00
Verona Pharma American Depositary Share (VRNA) GB $6.181B 0.00
Legend Biotech (LEGN) US $6.092B 0.00
Guardant Health (GH) US $5.804B 0.00
ADMA Biologics Inc (ADMA) US $5.589B 47.04
Nuvalent (NUVL) US $5.546B 0.00
Axsome Therapeutics (AXSM) US $5.523B 0.00
Zealand Pharma (ZLDPF) DK $5.337B 0.00
Alkermes (ALKS) IE $5.241B 14.06
Krystal Biotech (KRYS) US $4.802B 50.05
Vaxcyte (PCVX) US $4.565B 0.00
Cytokinetics (CYTK) US $4.452B 0.00
Rhythm Pharmaceuticals (RYTM) US $4.071B 0.00
PTC Therapeutics (PTCT) US $3.958B 0.00
Avidity Biosciences (RNA) US $3.881B 0.00
Ultragenyx Pharmaceutical (RARE) US $3.690B 0.00
Arcellx (ACLX) US $3.610B 0.00
Akero Therapeutics (AKRO) US $3.575B 0.00
SpringWorks Therapeutics (SWTX) US $3.467B 0.00
Zai Lab (ZLAB) CN $3.440B 0.00
CRISPR Therapeutics AG (CRSP) CH $3.303B 0.00
Viking Therapeutics (VKTX) US $3.297B 0.00
Scholar Rock Holding (SRRK) US $3.122B 0.00
Merus (MRUS) NL $3.057B 0.00
Xenon Pharmaceuticals (XENE) CA $2.932B 0.00
Protagonist Therapeutics (PTGX) US $2.820B 10.84
MoonLake Immunotherapeutics (MLTX) CH $2.709B 0.00
Metsera (MTSR) US $2.695B 0.00
Immunovant (IMVT) US $2.684B 0.00
HUTCHMED (China) (HCM) HK $2.615B 0.00
Apellis Pharmaceuticals (APLS) US $2.556B 0.00
ACADIA Pharmaceuticals (ACAD) US $2.495B 22.25
Alvotech (ALVO) LU $2.478B 0.00
Denali Therapeutics (DNLI) US $2.388B 0.00
Twist Bioscience (TWST) US $2.341B 0.00
Biohaven (BHVN) US $2.332B 0.00
Kymera Therapeutics (KYMR) US $2.297B 0.00
ImmunityBio (IBRX) US $2.242B 0.00
Ascentage Pharma Group - (AAPG) CN $2.219B 0.00
CG Oncology (CGON) US $2.214B 0.00
Mirum Pharmaceuticals (MIRM) US $2.161B 0.00
Ligand Pharmaceuticals (LGND) US $2.109B 0.00
Certara (CERT) US $2.098B 44.79
Amicus Therapeutics (FOLD) US $2.054B 222.33
Beam Therapeutics (BEAM) US $2.035B 0.00
NovoCure (NVCR) JE $2.023B 0.00
Kiniksa Pharmaceuticals (KNSA) GB $2.009B 0.00
Belite Bio (BLTE) US $1.995B 0.00
Tarsus Pharmaceuticals (TARS) US $1.990B 0.00
Arrowhead Pharmaceuticals (ARWR) US $1.980B 0.00
Vericel (VCEL) US $1.953B 216.39
Janux Therapeutics (JANX) US $1.945B 0.00
Bavarian Nordic (BVNRY) DK $1.897B 13.37
Travere Therapeutics (TVTX) US $1.878B 0.00
IDEAYA Biosciences (IDYA) US $1.833B 0.00
Arcutis Biotherapeutics (ARQT) US $1.817B 0.00
Apogee Therapeutics (APGE) US $1.801B 0.00
Edgewise Therapeutics (EWTX) US $1.772B 0.00
Agios Pharmaceuticals (AGIO) US $1.743B 0.00
Harmony Biosciences Holdings (HRMY) US $1.740B 12.08
Disc Medicine (IRON) US $1.712B 0.00
Vera Therapeutics (VERA) US $1.613B 0.00
ANI Pharmaceuticals (ANIP) US $1.588B 17.97
Structure Therapeutics (GPCR) US $1.553B 0.00
Mesoblast (MESO) AU $1.540B 0.00
Immunocore Holdings (IMCR) GB $1.525B 0.00
MannKind (MNKD) US $1.519B 31.25
Adaptive Biotechnologies (ADPT) US $1.495B 0.00
Dynavax Technologies (DVAX) US $1.387B 62.94
Celldex Therapeutics (CLDX) US $1.372B 0.00
Liquidia Technologies (LQDA) US $1.353B 0.00
89BIO (ETNB) US $1.274B 0.00
GRAIL (GRAL) US $1.263B 0.00
WAVE Life Sciences (WVE) SG $1.248B 0.00
Pacira BioSciences (PCRX) US $1.224B 11.50
Syndax Pharmaceuticals (SNDX) US $1.181B 0.00
Iovance Biotherapeutics (IOVA) US $1.169B 0.00
BGM Group (BGM) CN $1.138B 0.00
Viridian Therapeutics (VRDN) US $1.111B 0.00
Novavax (NVAX) US $1.031B 0.00
Mineralys Therapeutics (MLYS) US $1.000B 0.00
NeoGenomics (NEO) US $0.991B 0.00
Arcus Biosciences (RCUS) US $0.966B 0.00
Pharvaris (PHVS) NL $0.961B 0.00
MiMedx (MDXG) US $0.933B 22.57
Anbio Biotechnology (NNNN) DE $0.925B 0.00
Intellia Therapeutics (NTLA) US $0.916B 0.00
Spyre Therapeutics (SYRE) US $0.911B 0.00
Zymeworks (ZYME) US $0.902B 0.00
Geron (GERN) US $0.879B 0.00
Gyre Therapeutics (GYRE) US $0.868B 115.75
Nurix Therapeutics (NRIX) US $0.859B 0.00
Rocket Pharmaceuticals (RCKT) US $0.855B 0.00
Vir Biotechnology (VIR) US $0.850B 0.00
Nuvation Bio (NUVB) US $0.833B 0.00
Oculis Holding AG (OCS) CH $0.824B 0.00
Praxis Precision Medicines (PRAX) US $0.820B 0.00
LENZ Therapeutics (LENZ) US $0.813B 0.00
UniQure (QURE) NL $0.809B 0.00
Day One Biopharmaceuticals (DAWN) US $0.804B 0.00
Anavex Life Sciences (AVXL) US $0.799B 0.00
CureVac (CVAC) DE $0.799B 4.34
Regencell Bioscience Holdings (RGC) HK $0.797B 0.00
Bicara Therapeutics (BCAX) US $0.791B 0.00
Replimune (REPL) US $0.771B 0.00
Immunome (IMNM) US $0.770B 0.00
ArriVent BioPharma (AVBP) US $0.725B 0.00
AbCellera Biologics (ABCL) CA $0.719B 0.00
Trevi Therapeutics (TRVI) US $0.698B 0.00
Dianthus Therapeutics (DNTH) US $0.697B 0.00
Myriad Genetics (MYGN) US $0.697B 0.00
Arbutus Biopharma (ABUS) US $0.687B 0.00
Cogent Biosciences (COGT) US $0.668B 0.00
Sinovac Biotech (SVA) CN $0.645B 0.00
Bicycle Therapeutics (BCYC) GB $0.644B 0.00
CorMedix Inc (CRMD) US $0.636B 0.00
Zhengye Biotechnology Holding (ZYBT) CN $0.636B 0.00
Immatics (IMTX) DE $0.636B 37.36
Niagen Bioscience (NAGE) US $0.629B 200.00
AnaptysBio (ANAB) US $0.627B 0.00
Basilea Pharmaceutica AG (BPMUF) CH $0.626B 0.00
Pharming Group (PHGUF) NL $0.613B 0.00
Pharming Group (PHAR) NL $0.610B 0.00
Sionna Therapeutics (SION) US $0.599B 0.00
Keros Therapeutics (KROS) US $0.595B 0.00
GH Research (GHRS) IE $0.593B 0.00
MeiraGTx Holdings (MGTX) US $0.580B 0.00
Tyra Biosciences (TYRA) US $0.577B 0.00
Fortrea Holdings (FTRE) US $0.567B 18.41
Arvinas (ARVN) US $0.563B 0.00
Kura Oncology (KURA) US $0.560B 0.00
Castle Biosciences (CSTL) US $0.558B 31.21
Urogen Pharma (URGN) US $0.531B 0.00
Stoke Therapeutics (STOK) US $0.526B 0.00
Opthea (OPT) AU $0.525B 0.00
Mind Medicine (MindMed) (MNMD) US $0.522B 0.00
REGENXBIO (RGNX) US $0.521B 0.00
Cullinan Therapeutics (CGEM) US $0.519B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) US $0.502B 0.00
Zenas BioPharma (ZBIO) US $0.499B 0.00
Cytek Biosciences (CTKB) US $0.493B 0.00
Maze Therapeutics (MAZE) US $0.475B 0.00
Eton Pharmaceuticals (ETON) US $0.465B 0.00
Upstream Bio (UPB) US $0.464B 0.00
Precigen (PGEN) US $0.463B 0.00
Prothena (PRTA) IE $0.458B 0.00
Sage Therapeutics (SAGE) US $0.457B 0.00
Abivax SA (ABVX) FR $0.456B 0.00
Erasca (ERAS) US $0.448B 0.00
Northwest Biotherapeutics (NWBO) US $0.432B 0.00
Sana Biotechnology (SANA) US $0.426B 0.00
Mereo BioPharma Group - (MREO) GB $0.425B 0.00
PureTech Health (PRTC) US $0.422B 0.00
Oxford BioMedica (OXBDF) GB $0.416B 0.00
Rapport Therapeutics (RAPP) US $0.414B 0.00
Celcuity (CELC) US $0.412B 0.00
Ginkgo Bioworks Holdings (DNA) US $0.409B 0.00
Tectonic Therapeutic (TECX) US $0.406B 0.00
Oric Pharmaceuticals (ORIC) US $0.403B 0.00
MBX Biosciences (MBX) US $0.401B 0.00
Absci (ABSI) US $0.386B 0.00
Olema Pharmaceuticals (OLMA) US $0.384B 0.00
Kamada (KMDA) IL $0.383B 25.61
Allogene Therapeutics (ALLO) US $0.372B 0.00
Autolus Therapeutics (AUTL) GB $0.359B 0.00
Benitec Biopharma (BNTC) US $0.353B 0.00
Entrada Therapeutics (TRDA) US $0.350B 4.83
Alpha Teknova (TKNO) US $0.348B 0.00
Arcturus Therapeutics Holdings (ARCT) US $0.348B 0.00
Checkpoint Therapeutics (CKPT) US $0.345B 0.00
Solid Biosciences (SLDB) US $0.334B 0.00
Septerna (SEPN) US $0.333B 0.00
Cartesian Therapeutics (RNAC) US $0.329B 0.00
Abeona Therapeutics (ABEO) US $0.320B 0.00
ATyr Pharma (ATYR) US $0.320B 0.00
Aura Biosciences (AURA) US $0.309B 0.00
Monte Rosa Therapeutics (GLUE) US $0.306B 0.00
Terns Pharmaceuticals (TERN) US $0.306B 0.00
Fulcrum Therapeutics (FULC) US $0.303B 0.00
Astria Therapeutics (ATXS) US $0.302B 0.00
MaxCyte (MXCT) US $0.300B 0.00
ITeos Therapeutics (ITOS) US $0.297B 0.00
XOMA Royalty (XOMA) US $0.291B 0.00
Emergent Biosolutions (EBS) US $0.279B 0.00
Aardvark Therapeutics (AARD) US $0.279B 0.00
Monopar Therapeutics (MNPR) US $0.275B 0.00
Cidara Therapeutics (CDTX) US $0.272B 0.00
Palvella Therapeutics (PVLA) US $0.270B 0.00
Lifecore Biomedical (LFCR) US $0.270B 0.00
Vanda Pharmaceuticals (VNDA) US $0.269B 0.00
Gossamer Bio (GOSS) US $0.268B 0.00
2seventy Bio (TSVT) US $0.266B 0.00
Design Therapeutics (DSGN) US $0.264B 0.00
Compass Therapeutics (CMPX) US $0.261B 0.00
Candel Therapeutics (CADL) US $0.260B 0.00
ACELYRIN, INC (SLRN) US $0.259B 0.00
Atea Pharmaceuticals (AVIR) US $0.255B 0.00
Kodiak Sciences (KOD) US $0.253B 0.00
Prima BioMed (IMMP) AU $0.250B 0.00
Corvus Pharmaceuticals (CRVS) US $0.247B 0.00
Lexicon Pharmaceuticals (LXRX) US $0.246B 0.00
DBV Technologies S.A (DBVT) FR $0.245B 0.00
Rezolute (RZLT) US $0.242B 0.00
Neurogene (NGNE) US $0.242B 0.00
Foghorn Therapeutics (FHTX) US $0.236B 0.00
BioStem Technologies (BSEM) $0.234B 9.35
Third Harmonic Bio (THRD) US $0.233B 0.00
Bright Minds Biosciences (DRUG) US $0.227B 0.00
Amarin (AMRN) IE $0.226B 0.00
Ocugen (OCGN) US $0.223B 0.00
Prime Medicine (PRME) US $0.220B 0.00
Nuvectis Pharma (NVCT) US $0.218B 0.00
Alumis (ALMS) US $0.217B 0.00
Annexon (ANNX) US $0.216B 0.00
GENFIT S.A (GNFT) FR $0.214B 0.00
Adocia (ADOCY) FR $0.213B 0.00
Anika Therapeutics (ANIK) US $0.213B 0.00
ProQR Therapeutics (PRQR) NL $0.209B 0.00
Codexis (CDXS) US $0.209B 0.00
Actuate Therapeutics (ACTU) US $0.206B 0.00
Humacyte (HUMA) US $0.203B 0.00
Voyager Therapeutics (VYGR) US $0.201B 0.00
Y-mAbs Therapeutics (YMAB) US $0.200B 0.00
CARGO Therapeutics (CRGX) US $0.199B 0.00
Eledon Pharmaceuticals (ELDN) US $0.198B 0.00
EnGene Holdings (ENGN) CA $0.195B 0.00
Phathom Pharmaceuticals (PHAT) US $0.193B 0.00
Innate Pharma S.A (IPHA) FR $0.189B 0.00
Cardiff Oncology (CRDF) US $0.188B 0.00
Semper Paratus Acquisition (TVGN) US $0.186B 0.00
DiaMedica Therapeutics (DMAC) US $0.181B 0.00
INmune Bio (INMB) US $0.178B 0.00
Inventiva S.A (IVA) FR $0.177B 0.00
Inhibrx Biosciences (INBX) US $0.176B 0.00
Adherex Technologies (FENC) US $0.174B 0.00
AC Immune (ACIU) CH $0.173B 0.00
TuHURA Biosciences (HURA) US $0.171B 0.00
Sangamo Therapeutics (SGMO) US $0.167B 0.00
Molecular Partners AG (MOLN) CH $0.165B 0.00
Galena Biopharma (SLS) US $0.165B 0.00
Tango Therapeutics (TNGX) US $0.163B 0.00
Puma Biotechnology (PBYI) US $0.159B 5.26
BioAge Labs (BIOA) US $0.150B 0.00
Fate Therapeutics (FATE) US $0.150B 0.00
Tiziana Life Sciences (TLSA) GB $0.150B 0.00
Nkarta (NKTX) US $0.148B 0.00
Eupraxia Pharmaceuticals (EPRX) CA $0.144B 0.00
ADC Therapeutics SA (ADCT) CH $0.143B 0.00
Editas Medicine (EDIT) US $0.137B 0.00
Vigil Neuroscience (VIGL) US $0.135B 0.00
Greenwich LifeSciences (GLSI) US $0.133B 0.00
Compugen (CGEN) IL $0.132B 0.00
ScPharmaceuticals (SCPH) US $0.131B 0.00
Alector (ALEC) US $0.130B 0.00
Cuprina Holdings (Cayman) (CUPR) SG $0.128B 0.00
Rapt Therapeutics (RAPT) US $0.128B 0.00
Coherus BioSciences (CHRS) US $0.128B 0.00
Theratechnologies (THTX) CA $0.127B 0.00
Neumora Therapeutics (NMRA) US $0.126B 0.00
C4 Therapeutics (CCCC) US $0.124B 0.00
Seer (SEER) US $0.123B 0.00
Sagimet Biosciences (SGMT) US $0.117B 0.00
InflaRx (IFRX) DE $0.116B 0.00
Immunic (IMUX) US $0.110B 0.00
BioHarvest Sciences (BHST) CA $0.107B 0.00
Entera Bio (ENTX) IL $0.107B 0.00
Coya Therapeutics (COYA) US $0.107B 0.00
Contineum Therapeutics (CTNM) US $0.106B 0.00
Orchestra BioMed Holdings (OBIO) US $0.105B 0.00
Inozyme Pharma (INZY) US $0.105B 0.00
Zentalis Pharmaceuticals (ZNTL) US $0.104B 0.00
Pliant Therapeutics (PLRX) US $0.104B 0.00
Ventyx Biosciences (VTYX) US $0.103B 0.00
Alpha Cognition (ACOG) CA $0.102B 0.00
Black Diamond Therapeutics (BDTX) US $0.101B 0.00
Zura Bio (ZURA) US $0.101B 0.00
Genelux (GNLX) US $0.099B 0.00
Kyverna Therapeutics (KYTX) US $0.099B 0.00
HilleVax (HLVX) US $0.098B 0.00
Instil Bio (TIL) US $0.095B 0.00
Sutro Biopharma (STRO) US $0.093B 0.00
EXoZymes (EXOZ) US $0.091B 0.00
TScan Therapeutics (TCRX) US $0.091B 0.00
ANIXA BIOSCIENCES INC (ANIX) US $0.090B 0.00
CervoMed (CRVO) US $0.089B 0.00
XBiotech (XBIT) US $0.089B 0.00
Cellectis S.A (CLLS) FR $0.088B 0.00
Elicio Therapeutics (ELTX) US $0.088B 0.00
Senti Biosciences (SNTI) US $0.087B 0.00
Climb Bio (CLYM) US $0.086B 0.00
Nautilus Biotechnology (NAUT) US $0.085B 0.00
Seres Therapeutics (MCRB) US $0.084B 0.00
Elutia (ELUT) US $0.083B 0.00
Vor Biopharma (VOR) $0.083B 0.00
Biomea Fusion (BMEA) US $0.082B 0.00
Caribou Biosciences (CRBU) US $0.082B 0.00
Jasper Therapeutics (JSPR) US $0.081B 0.00
IGM Biosciences (IGMS) US $0.081B 0.00
I-Mab (IMAB) US $0.077B 0.00
Invivyd (IVVD) US $0.075B 0.00
MediciNova (MNOV) US $0.074B 0.00
Adaptimmune Therapeutics (ADAP) GB $0.074B 0.00
Adverum Biotechnologies (ADVM) US $0.073B 0.00
Genenta Science S.p.A (GNTA) IT $0.073B 0.00
Adagene (ADAG) CN $0.072B 0.00
VTv Therapeutics (VTVT) US $0.072B 0.00
Adlai Nortye (ANL) KY $0.071B 0.00
Inovio Pharmaceuticals (INO) US $0.070B 0.00
Milestone Pharmaceuticals (MIST) CA $0.070B 0.00
Skye Bioscience (SKYE) US $0.069B 0.00
VistaGen Therapeutics (VTGN) US $0.069B 0.00
BeyondSpring (BYSI) US $0.068B 0.00
Cabaletta Bio (CABA) US $0.068B 0.00
Exicure (XCUR) US $0.068B 0.00
Clearside Biomedical (CLSD) US $0.067B 0.00
IO Biotech (IOBT) DK $0.067B 0.00
Citius Oncology (CTOR) US $0.066B 0.00
Alto Neuroscience (ANRO) US $0.066B 0.00
Agenus (AGEN) US $0.066B 0.00
Acumen Pharmaceuticals (ABOS) US $0.065B 0.00
Applied Therapeutics (APLT) US $0.065B 0.00
Prenetics Global (PRE) HK $0.065B 0.00
CytomX Therapeutics (CTMX) US $0.065B 2.11
PDS Biotechnology (PDSB) US $0.063B 0.00
Rani Therapeutics Holdings (RANI) US $0.062B 0.00
Repare Therapeutics (RPTX) CA $0.061B 0.00
Akoya Biosciences (AKYA) US $0.061B 0.00
Achilles Therapeutics (ACHL) GB $0.061B 0.00
Precision BioSciences (DTIL) US $0.061B 0.00
Ikena Oncology (IKNA) US $0.060B 0.00
Artiva Biotherapeutics (ARTV) US $0.059B 0.00
Medicus Pharma (MDCX) US $0.059B 0.00
Immix Biopharma (IMMX) US $0.058B 0.00
Adicet Bio (ACET) US $0.055B 0.00
Fortress Biotech (FBIO) US $0.054B 0.00
Renovaro (RENB) US $0.053B 0.00
ZIVO Bioscience (ZIVO) US $0.053B 0.00
Cyclacel Pharmaceuticals (CYCC) US $0.052B 0.00
PepGen (PEPG) US $0.052B 0.00
Biodexa Pharmaceuticals (BDRX) GB $0.051B 0.00
Oncobiologics (OTLK) US $0.050B 0.00
Mersana Therapeutics (MRSN) US $0.050B 0.00
Shattuck Labs (STTK) US $0.048B 0.00
Oncolytics Biotech (ONCY) CA $0.048B 0.00
Anebulo Pharmaceuticals (ANEB) US $0.047B 0.00
Quince Therapeutics (QNCX) US $0.047B 0.00
Atara Biotherapeutics (ATRA) US $0.047B 0.00
Cue Biopharma (CUE) US $0.047B 0.00
OKYO Pharma (OKYO) $0.046B 0.00
Forte Biosciences (FBRX) US $0.046B 0.00
Connect Biopharma Holdings (CNTB) US $0.046B 0.00
Tenaya Therapeutics (TNYA) US $0.046B 0.00
Immuneering (IMRX) US $0.045B 0.00
Opus Genetics (IRD) US $0.043B 0.00
Kronos Bio (KRON) US $0.043B 0.00
Whitehawk Therapeutics (WHWK) US $0.043B 0.00
Advanced Biomed (ADVB) US $0.042B 0.00
Estrella Immunopharma (ESLA) US $0.042B 0.00
Tvardi Therapeutics (TVRD) US $0.041B 0.00
Werewolf Therapeutics (HOWL) US $0.041B 0.00
TELA Bio (TELA) US $0.040B 0.00
Rein Therapeutics (RNTX) US $0.040B 0.00
CAMP4 Therapeutics (CAMP) US $0.039B 0.00
Xilio Therapeutics (XLO) US $0.039B 0.00
Bluebird Bio (BLUE) US $0.039B 0.00
FibroBiologics (FBLG) US $0.039B 0.00
Lantern Pharma (LTRN) US $0.038B 0.00
Celularity (CELU) US $0.038B 0.00
Scilex Holding (SCLX) US $0.038B 0.00
Barinthus Biotherapeutics (BRNS) GB $0.037B 0.00
AN2 Therapeutics (ANTX) US $0.037B 0.00
Akari Therapeutics (AKTX) GB $0.037B 0.00
RenovoRx (RNXT) US $0.037B 0.00
Spero Therapeutics (SPRO) US $0.036B 0.00
Dyadic (DYAI) US $0.036B 0.00
Boundless Bio (BOLD) US $0.036B 0.00
Pluri (PLUR) IL $0.034B 0.00
Aligos Therapeutics (ALGS) US $0.034B 0.00
LAVA Therapeutics (LVTX) NL $0.034B 0.00
OnKure Therapeutics (OKUR) US $0.034B 0.00
Kezar Life Sciences (KZR) US $0.033B 0.00
BioAtla (BCAB) US $0.033B 0.00
Cadrenal Therapeutics (CVKD) US $0.032B 0.00
Femasys (FEMY) US $0.032B 0.00
Radiopharm Theranostics - (RADX) AU $0.031B 0.00
Grace Therapeutics (GRCE) CA $0.031B 0.00
Alterity Therapeutics - (ATHE) AU $0.031B 0.00
MiNK Therapeutics (INKT) US $0.030B 0.00
Allakos (ALLK) US $0.029B 0.00
Kalaris Therapeutics (KLRS) US $0.029B 0.00
Generation Bio (GBIO) US $0.029B 0.00
ALX Oncology Holdings (ALXO) US $0.028B 0.00
Cognition Therapeutics (CGTX) US $0.028B 0.00
Coeptis Therapeutics Holdings (COEP) US $0.027B 0.00
Clene (CLNN) US $0.027B 0.00
Dare Bioscience (DARE) US $0.026B 0.00
CollPlant Biotechnologies (CLGN) IL $0.025B 0.00
Passage Bio (PASG) US $0.025B 0.00
CalciMedica (CALC) US $0.024B 0.00
KALA BIO (KALA) US $0.024B 0.00
Tenax Therapeutics (TENX) US $0.024B 0.00
Longeveron (LGVN) US $0.023B 0.00
Ovid Therapeutics (OVID) US $0.023B 0.00
Annovis Bio (ANVS) US $0.023B 0.00
Cardio Diagnostics Holdings (CDIO) US $0.022B 0.00
X4 Pharmaceuticals (XFOR) US $0.022B 0.00
Quantum Biopharma (QNTM) CA $0.021B 0.00
Promis Neurosciences (PMN) CA $0.021B 0.00
Lexaria Bioscience (LEXX) CA $0.021B 0.00
Lisata Therapeutics (LSTA) US $0.021B 0.00
Elevation Oncology (ELEV) US $0.021B 0.00
Curis (CRIS) US $0.020B 0.00
Chemomab Therapeutics (CMMB) IL $0.020B 0.00
Q32 Bio (QTTB) US $0.020B 0.00
MIRA Pharmaceuticals (MIRA) US $0.020B 0.00
UNITY Biotechnology (UBX) US $0.019B 0.00
Allarity Therapeutics (ALLR) US $0.019B 0.00
ABVC BioPharma (ABVC) US $0.018B 0.00
Beyond Air (XAIR) US $0.018B 0.00
Gelteq (GELS) AU $0.017B 0.00
Leap Therapeutics (LPTX) US $0.017B 0.00
Cingulate (CING) US $0.017B 0.00
Edesa Biotech (EDSA) CA $0.017B 0.00
Aspire Biopharma Holdings (ASBP) US $0.017B 0.00
HOOKIPA Pharma (HOOK) US $0.016B 0.00
Affimed (AFMD) DE $0.015B 0.00
GeoVax Labs (GOVX) US $0.015B 0.00
Equillium (EQ) US $0.015B 0.00
SAB Biotherapeutics (SABS) US $0.015B 0.00
BRIACELL THERAP (BCTX) CA $0.015B 0.00
Moleculin Biotech (MBRX) US $0.014B 0.00
NeuroSense Therapeutics (NRSN) IL $0.014B 0.00
Synlogic (SYBX) US $0.014B 0.00
Biorestorative Therapies (BRTX) US $0.014B 0.00
IN8bio (INAB) US $0.014B 0.00
BioCardia (BCDA) US $0.014B 0.00
Bolt Biotherapeutics (BOLT) US $0.014B 0.00
Rallybio (RLYB) US $0.013B 0.00
Bionano Genomics (BNGO) US $0.013B 0.00
NextCure (NXTC) US $0.012B 0.00
Imunon (IMNN) US $0.012B 0.00
Abpro Holdings (ABP) US $0.012B 0.00
Hoth Therapeutics (HOTH) US $0.012B 0.00
COSCIENS Biopharma (CSCI) CA $0.012B 0.00
Athira Pharma (ATHA) US $0.011B 0.00
IMMURON (IMRN) AU $0.011B 0.00
LakeShore Biopharma (LSB) CN $0.011B 0.00
Portage Biotech (PRTG) $0.011B 0.00
Sensei Biotherapeutics (SNSE) US $0.011B 0.00
Aerovate Therapeutics (JBIO) US $0.010B 0.00
Aprea Therapeutics (APRE) US $0.010B 0.00
Cyclerion Therapeutics (CYCN) US $0.010B 0.00
IBio (IBIO) US $0.010B 0.00
BioXcel Therapeutics (BTAI) US $0.010B 0.00
Dogwood Therapeutics (DWTX) US $0.010B 0.00
Acurx Pharmaceuticals (ACXP) US $0.009B 0.00
Neuphoria Therapeutics (NEUP) AU $0.009B 0.00
Creative Medical Technology Holdings (CELZ) US $0.009B 0.00
Intensity Therapeutics (INTS) US $0.009B 0.00
Silexion Therapeutics Corp (SLXN) IL $0.009B 0.00
HCW Biologics (HCWB) US $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) US $0.008B 0.00
BioAffinity Technologies (BIAF) US $0.008B 0.00
Turnstone Biologics (TSBX) US $0.008B 0.00
Aytu BioPharma (AYTU) US $0.008B 0.00
GENPREX (GNPX) US $0.007B 0.00
Apollomics (APLM) US $0.007B 0.00
Biofrontera (BFRI) US $0.007B 0.00
MetaVia (MTVA) US $0.007B 0.00
Mainz Biomed (MYNZ) DE $0.007B 0.00
Lipella Pharmaceuticals (LIPO) US $0.006B 0.00
Avalon GloboCare (ALBT) US $0.006B 0.00
Evogene (EVGN) IL $0.006B 0.00
180 Life Sciences (ATNF) US $0.006B 0.00
GT Biopharma (GTBP) US $0.006B 0.00
Dermata Therapeutics (DRMA) US $0.005B 0.00
Soligenix (SNGX) US $0.005B 0.00
Arcadia Biosciences (RKDA) US $0.005B 0.00
Onconetix (ONCO) US $0.005B 0.00
Alzamend Neuro (ALZN) US $0.004B 0.00
Adial Pharmaceuticals (ADIL) US $0.004B 0.00
Polyrizon (PLRZ) IL $0.004B 0.00
Ensysce Biosciences (ENSC) US $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) US $0.004B 0.00
Pasithea Therapeutics (KTTA) US $0.004B 0.00
Galecto (GLTO) DK $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) US $0.004B 0.00
Novogen (KZIA) AU $0.004B 0.00
VivoSim Labs (VIVS) US $0.004B 0.00
Sunshine Biopharma (SBFM) US $0.004B 0.00
Windtree Therapeutics (WINT) US $0.004B 0.00
Mustang Bio (MBIO) US $0.004B 0.00
Palisade Bio (PALI) US $0.003B 0.00
Titan Pharmaceuticals (TTNP) US $0.003B 0.00
Tharimmune (THAR) US $0.003B 0.00
Silo Pharma (SILO) US $0.003B 0.00
Synaptogenix (SNPX) US $0.003B 0.00
Artelo Biosciences (ARTL) US $0.003B 0.00
CNS Pharmaceuticals (CNSP) US $0.003B 0.00
Eyenovia (EYEN) US $0.003B 0.00
Virax Biolabs Group (VRAX) GB $0.003B 0.00
Enveric Biosciences (ENVB) US $0.003B 0.00
Hepion Pharmaceuticals (HEPA) US $0.003B 0.00
Purple Biotech (PPBT) IL $0.003B 0.00
Aptevo Therapeutics (APVO) US $0.003B 0.00
NuCana (NCNA) GB $0.003B 0.00
Scinai Immunotherapeutics (SCNI) IL $0.003B 0.00
Revelation Biosciences (REVB) US $0.003B 0.00
AquaBounty Technologies (AQB) US $0.003B 0.00
Bone Biologics (BBLG) US $0.002B 0.00
Evaxion Biotech (EVAX) DK $0.002B 0.00
Psyence Biomedical (PBM) CA $0.002B 0.00
Atrinsic (PTIX) US $0.002B 0.00
Entero Therapeutics (ENTO) US $0.002B 0.00
ZyVersa Therapeutics (ZVSA) US $0.002B 0.00
NAYA Biosciences (IVF) US $0.001B 0.00
GRI Bio (GRI) US $0.001B 0.00
Capstone Therapeutics (CAPS) US $0.000B 0.00
TFF Pharmaceuticals (TFFP) US $0.000B 0.00
Aceragen (ACGN) US $0.000B 0.00
ARAVIVE, INC (ARAV) US $0.000B 0.00
Clovis Oncology (CLVSQ) US $0.000B 0.00
Cocrystal Pharma (COCP) US $0.000B 0.00
Celyad SA (CYAD) BE $0.000B 0.00
CytoMed Therapeutics (GDTC) SG $0.000B 0.00
Galapagos (GLPG) BE $0.000B 0.00
Motif Bio Plc (MTFB) GB $0.000B 0.00
PDL BioPharma (PDLI) US $0.000B 0.00
Pulmatrix (PULM) US $0.000B 0.00
VectivBio Holding AG (VECT) CH $0.000B 0.00